Tag: Merck & Co.
GENERAL Aurobindo Pharma Signs Licensing Agreement With MSD For HIV Drug

Aurobindo Pharma Ltd  has entered into a non-exclusive voluntary licensing agreement with MSD (the trade name of Merck & Co., Inc., Rahway, New Jersey, USA) to manufacture and supply a generic version of the investigational HIV prevention medicine, Alimatravir, in eligible low- and middle-income countries. Aurobindo Pharma is among a select group of global generic […]

CW Bureau · Jul 25, 2026
GENERAL Sun Pharmaceuticals To Acquire Organon In $11.75-Bn All-Cash Deal

Sun Pharmaceutical Industries Ltd, leading specialty generics company, will acquire Organon at $14 per share in an all-cash transaction, valuing the company at an enterprise value of $11.75 billion, funded through internal accruals and borrowings. The transaction will be executed through a merger of Organon with a subsidiary of Sun Pharma, with Organon surviving the […]

CW Bureau · Apr 27, 2026